Cholesterol biosynthesis inhibition synergizes with AKT inhibitors in triple-negative breast cancer
A. Toker, A. L. Hillis, T. D. Martin…·R. R. Madsen
This study identifies a synergistic effect between AKT inhibitors and pitavastatin in killing triple-negative breast cancer cells by targeting cholesterol trafficking.